Overview

Photodynamic Therapy During Surgery in Treating Patients With Pleural Malignancy

Status:
Withdrawn
Trial end date:
2016-01-29
Target enrollment:
Participant gender:
Summary
This pilot clinical trial studies photodynamic therapy during surgery in treating patients with pleural (the protective lining or membrane that covers the lungs and chest cavity) malignancy. Photodynamic therapy is an anti-cancer treatment that combines a photosensitizer (a substance that makes cells more sensitive to light), such as porfimer sodium, together with oxygen and visible light to kill tumor cells and/or damage the tumor's blood supply. Intraoperative (during surgery) photodynamic therapy may kill any tumor cells that remain after surgery.
Phase:
N/A
Details
Lead Sponsor:
Ohio State University Comprehensive Cancer Center
Treatments:
Dihematoporphyrin Ether
Trioxsalen